ERBB2 and cancer: COX2 contributes to increased anti-apoptotic, pro-angiogenic, and metastatic potential in cancer cells, and deregulation of COX2 expression was associated with tumor progression, suggesting that COX2 overexpression induced by nuclear ErbB2/HER2 in cancer cells may be a marker of bad prognosis.